EW Earnings Edwards Lifesciences
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | 1.07 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.66 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | 1.83 | 2026-02-25 | 10-K |
| Q3 2025 | 2025-09-30 | 1.67 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | 1.18 | 2026-08-04 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.61 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | 6.97 | 2026-02-25 | 10-K |
| Q3 2025 | 2024-09-30 | 6.29 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.19 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.58 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | 2.30 | 2026-02-25 | 10-K |
| FY 2024 | 2023-09-30 | 0.63 | 2025-02-28 | 10-K |
| FY 2024 | 2023-06-30 | 0.50 | 2025-02-28 | 10-K |
| FY 2024 | 2023-03-31 | 0.56 | 2025-02-28 | 10-K |
| FY 2024 | 2022-12-31 | 2.44 | 2025-02-28 | 10-K |
| Q3 2023 | 2022-09-30 | 1.79 | 2023-10-27 | 10-Q |
| Q2 2023 | 2022-06-30 | 1.24 | 2023-07-28 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.59 | 2023-04-28 | 10-Q |
| FY 2023 | 2021-12-31 | 2.38 | 2024-02-12 | 10-K |
| Q3 2022 | 2021-09-30 | 1.85 | 2022-10-28 | 10-Q |
| Q2 2022 | 2021-06-30 | 1.31 | 2022-07-29 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.54 | 2022-04-28 | 10-Q |
| FY 2022 | 2020-12-31 | 1.30 | 2023-02-13 | 10-K |
| Q3 2021 | 2020-09-30 | 0.82 | 2021-10-29 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.30 | 2021-07-30 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.49 | 2021-04-28 | 10-Q |
| FY 2021 | 2019-12-31 | 1.64 | 2022-02-14 | 10-K |
| FY 2020 | 2019-09-30 | 0.43 | 2021-02-12 | 10-K |
| FY 2020 | 2019-06-30 | 0.38 | 2021-02-12 | 10-K |
| FY 2020 | 2019-03-31 | 0.39 | 2021-02-12 | 10-K |
| FY 2020 | 2018-12-31 | 1.13 | 2021-02-12 | 10-K |
| FY 2019 | 2018-09-30 | 1.06 | 2020-02-14 | 10-K |
| FY 2019 | 2018-06-30 | 1.32 | 2020-02-14 | 10-K |
| FY 2019 | 2018-03-31 | 0.96 | 2020-02-14 | 10-K |
| FY 2019 | 2017-12-31 | 2.70 | 2020-02-14 | 10-K |
| FY 2018 | 2017-09-30 | 0.79 | 2019-02-15 | 10-K |
| FY 2018 | 2017-06-30 | 0.86 | 2019-02-15 | 10-K |
| FY 2018 | 2017-03-31 | 1.06 | 2019-02-15 | 10-K |
| FY 2018 | 2016-12-31 | 2.61 | 2019-02-15 | 10-K |
| FY 2017 | 2016-09-30 | 0.65 | 2018-02-16 | 10-K |
| FY 2017 | 2016-06-30 | 0.58 | 2018-02-16 | 10-K |
| FY 2017 | 2016-03-31 | 0.66 | 2018-02-16 | 10-K |
| FY 2017 | 2015-12-31 | 2.25 | 2018-02-16 | 10-K |
| FY 2016 | 2015-09-30 | 0.54 | 2017-02-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.